The novel GIP, GLP-1 and glucagon receptor agonist Retatrutide delays gastric emptying
Its still a grey area where regulation hasnt caught up, clinics are charging high markups, and transparency is lacking
Clinical data from the CJC-1295 DAC trials showed dose-dependent GH increases of 2 to 10-fold lasting 6 days or more after a single injection
[7] [2] By 1986, the major review of the field by Graf and Kastin concluded that the various physiological functions of DSIP and its mechanism of action remain to be established. [2] That sentence was written four decades ago and has not been superseded
Female mice and rats displayed greater nausea-associated behaviors after receiving GLP-1 drugs, mirroring human data
Regulators focus on substance, use, and context rather than disclaimers